Myocardial-directed overexpression of the human β1-adrenergic receptor in transgenic mice

被引:213
|
作者
Bisognano, JD
Weinberger, HD
Bohlmeyer, TJ
Pende, A
Raynolds, MV
Sastravaha, A
Roden, R
Asano, K
Blaxall, BC
Wu, SC
Communal, C
Singh, K
Colucci, W
Bristow, MR
Port, JD
机构
[1] Univ Colorado, Hlth Sci Ctr, Dept Med, Div Cardiol, Denver, CO 80262 USA
[2] Univ Colorado, Hlth Sci Ctr, Dept Pharmacol, Denver, CO 80262 USA
[3] Boston Univ, VA Med Ctr, Div Cardiol, Boston, MA 02118 USA
关键词
beta adrenergic receptors; transgenic mice; heart failure; apoptosis;
D O I
10.1006/jmcc.2000.1123
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The beta(1)-adrenergic receptor (AR) is the dominant subtype in non-failing and Failing myocardium. beta(1)-AR signaling, by the endogenous neurotransmitter norepinephrine, is central to the regulation of myocardial contractility. In heart failure, the beta(1)-AR undergoes subtype-selective downregulation which may protect, against the increased cardiac adrenergic drive associated with this pathophysiological stale. To examine the hypothesis that chronically increased beta(1)-AR mediated signaling has adverse myocardial effects, transgenic mice overexpressing the human beta(1)-AR in a cardiac-selective context were produced, utilizing an alpha-myosin heavy chain (MHC) promoter. In these mice, beta(1)-AR protein abundance was similar to 24-46-fold (1-2 pmol/mg protein) that of wild-type mice. Histopathological examination of young (4 months old) and old (greater than or equal to 9 months old) transgenic mouse hearts consistently demonstrated large areas of interstitial replacement fibrosis, marked myocyte hypertrophy and myofibrilar disarray. In addition, increased expression of the pre-apoptotic marker. Bax, was observed coincident with regions of fibrosis accompanied by an increased apoptotic index, as measured by TUNEL assay. Older non-transgenic mice exhibited a slight tendency towards a decreased fractional shortening, whereas older beta(1)-AR transgenic mice had a marked reduction in fractional shortening (%FS similar to 30) as determined by echocardiography. Additionally, older beta(1)-AR transgenic mice had an increased left ventricular chamber size. In summary, cardiac-directed overexpression of the human beta(1)-AR in transgenic mice leads to a significant histopathological phenotype with no apparent functional consequence in younger mice and a variable degree of cardiac dysfunction in older animals. This model system may ultimately prove useful for investigating the biological basis of adrenergically-mediated myocardial damage in humans. (C) 2000 Academic Press.
引用
收藏
页码:817 / 830
页数:14
相关论文
共 50 条
  • [21] Temporal analysis of mRNA and miRNA expression in transgenic mice overexpressing Arg- and Gly389 polymorphic variants of the β1-adrenergic receptor
    Dockstader, Karen
    Nunley, Karin
    Karimpour-Fard, Anis
    Medway, Allen
    Nelson, Penny
    Port, J. David
    Liggett, Stephen B.
    Bristow, Michael R.
    Sucharov, Carmen C.
    PHYSIOLOGICAL GENOMICS, 2011, 43 (23) : 1294 - 1306
  • [22] Myocardial recovery after ischemia and reperfusion injury is significantly impaired in hearts with transgenic overexpression of β-adrenergic receptor kinase
    Chen, EP
    Bittner, HB
    Akhter, SA
    Koch, WJ
    Davis, RD
    CIRCULATION, 1998, 98 (19) : II249 - II253
  • [23] Pro-inflammatory responses in human monocytes are β1-adrenergic receptor subtype dependent
    Grisanti, Laurel A.
    Evanson, Janel
    Marchus, Erica
    Jorissen, Heather
    Woster, Andrew P.
    DeKrey, Wanda
    Sauter, Edward R.
    Combs, Colin K.
    Porter, James E.
    MOLECULAR IMMUNOLOGY, 2010, 47 (06) : 1244 - 1254
  • [24] Human β1-Adrenergic Receptor Is Subject to Constitutive and Regulated N-terminal Cleavage
    Hakalahti, Anna E.
    Vierimaa, Miia M.
    Lilja, Minna K.
    Kumpula, Esa-Pekka
    Tuusa, Jussi T.
    Petaja-Repo, Ulla E.
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2010, 285 (37) : 28850 - 28861
  • [25] Agonistic anti-β1-adrenergic receptor autoantibodies from cardiomyopathy patients reduce the β1-adrenergic receptor expression in neonatal rat cardiomyocytes
    Podlowski, S
    Luther, HP
    Morwinski, R
    Müller, J
    Wallukat, G
    CIRCULATION, 1998, 98 (22) : 2470 - 2476
  • [26] Partial agonist activity of bucindolol is dependent on the activation state of the human β1-adrenergic receptor
    Maack, C
    Böhm, M
    Vlaskin, L
    Dabew, E
    Lorenz, K
    Schäfers, HJ
    Lohse, MJ
    Engelhardt, S
    CIRCULATION, 2003, 108 (03) : 348 - 353
  • [27] Differential Regulation of Two Palmitoylation Sites in the Cytoplasmic Tail of the β1-Adrenergic Receptor
    Zuckerman, David M.
    Hicks, Stuart W.
    Charron, Guillaume
    Hang, Howard C.
    Machamer, Carolyn E.
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2011, 286 (21) : 19014 - 19023
  • [28] N-Tertaining a New Signaling Paradigm for the Cardiomyocyte β1-Adrenergic Receptor
    Steinberg, Susan F.
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2022, 80 (03) : 328 - 333
  • [29] Honokiol Protects against Anti-β1-Adrenergic Receptor Autoantibody-Induced Myocardial Dysfunction via Activation of Autophagy
    Wei, Xi-qing
    Zhang, Hong-sheng
    Wei, Guang-he
    Zhang, Jin-guo
    Du, Yan-yan
    Tan, Hong-yong
    Yang, Jun
    OXIDATIVE MEDICINE AND CELLULAR LONGEVITY, 2018, 2018
  • [30] Myocardial hypertrophy in transgenic mice overexpressing human interleukin 1α
    Isoda, K
    Kamezawa, Y
    Tada, N
    Sato, M
    Ohsuzu, F
    JOURNAL OF CARDIAC FAILURE, 2001, 7 (04) : 355 - 364